Dexcom Inc (DXCM)

$69.28 -0.97 (-1.38%)
Market Cap 27.68B
Revenue (ttm) 4.03B
Net Income (ttm) 576.20M
EPS (ttm) N/A
PE Ratio 36.24
Forward PE 27.32
Profit Margin 14.29%
Debt to Equity Ratio 0.45
Volume 2,733,912
Avg Vol 6,426,166
Day's Range N/A - N/A
Shares Out 390.02M
Stochastic %K 69%
Beta 1.48
Analysts Strong Sell
Price Target $85.56

Company Profile

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized thir...

Industry: Medical Devices
Sector: Healthcare
Phone: 858 200 0200
Address:
6340 Sequence Drive, San Diego, United States
ckjamesst
ckjamesst Jan. 14 at 6:28 PM
$DXCM 67.62 is great close
0 · Reply
ckjamesst
ckjamesst Jan. 14 at 6:25 PM
$DXCM lets go to 66 boys
0 · Reply
ckjamesst
ckjamesst Jan. 14 at 3:38 PM
$DXCM don’t buy fk them bro. They want you to buy here so they can exit lol buy long puts :) gl
0 · Reply
ckjamesst
ckjamesst Jan. 14 at 3:28 PM
$DXCM 5k position entered
0 · Reply
DiamondCapital
DiamondCapital Jan. 14 at 2:27 PM
$ADHC Very attractive at 1M market cap Quick DD •GlucoGuard, diabetes medical device •FDA Breakthrough Device pending •Partnership with $DXCM a $27B co •Hedgefund backing •CFA Analyst coverage •Impressive team, including former FDA official Stephen Weber •University of California Irvine collab CFA Analyst report issued by Harbinger Research dated June 2, 2025 with a “Strong Speculative Buy” Rating with a price target of .012 or $43M valuation Link to the research report: https://d1io3yog0oux5.cloudfront.net/harbingerresearch/media/cf29499818e4263671232f93c2967e52.pdf By Brian R. Connell, CFA Senior Research Analyst | Harbinger Research
0 · Reply
ckjamesst
ckjamesst Jan. 14 at 12:37 PM
$DXCM please buy 2 weeks puts on this weak stock watch they are going to announce some bs soon either this week or next week I think spinning top is in play!
0 · Reply
ckjamesst
ckjamesst Jan. 14 at 12:25 PM
$DXCM to everyone who thinks this will go…. This is just for you all I am giving my buy zone area! I might be wrong but guess what I might be right as well. Next week is disaster.. trust the process. Can 58 or 59 is a buying zone ??
0 · Reply
ckjamesst
ckjamesst Jan. 14 at 12:09 AM
$DXCM this guy is a scammer
0 · Reply
ckjamesst
ckjamesst Jan. 13 at 11:45 PM
$DXCM tomorrow play is very simple: bull will try hard to push but they will fail. Huge rejection coming. If this moves slow expect it to drop till Monday next week. If it moves faster and drop then expect 62 or lower this week expecting 7-8% drop in few days
1 · Reply
Mobagri
Mobagri Jan. 13 at 11:03 PM
$DXCM https://stocks.apple.com/AK6kNTAPTRRSECTfBH86IXA
0 · Reply
Latest News on DXCM
Watch CNBC's exclusive interview with Dexcom CEO Jake Leach

Jan 13, 2026, 5:24 PM EST - 20 hours ago

Watch CNBC's exclusive interview with Dexcom CEO Jake Leach

DexCom, Inc. (DXCM) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 13, 2026, 3:35 PM EST - 21 hours ago

DexCom, Inc. (DXCM) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook

Jan 12, 2026, 7:30 AM EST - 2 days ago

Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook

Dexcom Enters Next Era of Continued Innovation With Jake Leach as President and Chief Executive Officer

Jan 7, 2026, 9:00 AM EST - 7 days ago

Dexcom Enters Next Era of Continued Innovation With Jake Leach as President and Chief Executive Officer

HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Dec 24, 2025, 11:45 AM EST - 21 days ago

HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. Lawsuit – DXCM

Dec 22, 2025, 3:50 PM EST - 22 days ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. Lawsuit – DXCM

Halper Sadeh LLC Encourages DexCom, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Dec 18, 2025, 1:21 PM EST - 27 days ago

Halper Sadeh LLC Encourages DexCom, Inc. Shareholders to Contact the Firm to Discuss Their Rights

4 Reasons Why DexCom Could Be A Good Buy For 2026

Dec 16, 2025, 7:37 AM EST - 4 weeks ago

4 Reasons Why DexCom Could Be A Good Buy For 2026

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. Lawsuit - DXCM

Dec 11, 2025, 9:00 AM EST - 4 weeks ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. Lawsuit - DXCM

High-Quality Compounders With Both Pricing Power And Idiosyncratic Growth

Dec 11, 2025, 3:45 AM EST - 4 weeks ago

High-Quality Compounders With Both Pricing Power And Idiosyncratic Growth

ABT AI ASND AXON AZO CPRT HOOD

Bragar Eagel & Squire, P.C. Urges DexCom and Wildermuth Investors to Contact the Firm Regarding Their Rights Before Upcoming Deadlines

Dec 4, 2025, 6:11 PM EST - 5 weeks ago

Bragar Eagel & Squire, P.C. Urges DexCom and Wildermuth Investors to Contact the Firm Regarding Their Rights Before Upcoming Deadlines

Listening to Healthcare Professionals: Dexcom Launches New Education Offering, Dexcom Academy

Dec 4, 2025, 8:02 AM EST - 5 weeks ago

Listening to Healthcare Professionals: Dexcom Launches New Education Offering, Dexcom Academy

Virtus Silvant Mid-Cap Growth Fund Q3 2025 Performance Review

Nov 26, 2025, 1:38 PM EST - 6 weeks ago

Virtus Silvant Mid-Cap Growth Fund Q3 2025 Performance Review

AFRM AJG ALAB ALNY AXON FICO HOOD

Touchstone Sands Capital Select Growth Fund Q3 Contributors And Detractors

Nov 26, 2025, 1:40 AM EST - 7 weeks ago

Touchstone Sands Capital Select Growth Fund Q3 Contributors And Detractors

APP AVGO AXON DDOG GOOG GOOGL ICE

Bragar Eagel & Squire, P.C. Urges DexCom and Wildermuth Investors to Contact the Firm Regarding Their Rights

Nov 25, 2025, 7:15 PM EST - 7 weeks ago

Bragar Eagel & Squire, P.C. Urges DexCom and Wildermuth Investors to Contact the Firm Regarding Their Rights

GlucoGuard a Division of American Diversified Holdings (ADHC) Successfully Submits Level 2 App Integration Through Dexcom's Developer Partner Program

Nov 25, 2025, 9:00 AM EST - 7 weeks ago

GlucoGuard a Division of American Diversified Holdings (ADHC) Successfully Submits Level 2 App Integration Through Dexcom's Developer Partner Program

Ademi & Fruchter LLP Investigates Claims of Securities Fraud against DexCom, Inc.

Nov 24, 2025, 10:00 AM EST - 7 weeks ago

Ademi & Fruchter LLP Investigates Claims of Securities Fraud against DexCom, Inc.

Dexcom G7 15 Day Continuous Glucose Monitoring System to Launch on Dec. 1 in the United States

Nov 20, 2025, 8:30 AM EST - 7 weeks ago

Dexcom G7 15 Day Continuous Glucose Monitoring System to Launch on Dec. 1 in the United States

Dexcom partners with Disabled American Veterans as part of new strategic initiative

Nov 19, 2025, 11:05 AM EST - 2 months ago

Dexcom partners with Disabled American Veterans as part of new strategic initiative

Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes

Nov 19, 2025, 8:30 AM EST - 2 months ago

Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes

These stocks have been hit hard in 2025 but could surge by as much as 57% from here

Nov 17, 2025, 11:24 AM EST - 2 months ago

These stocks have been hit hard in 2025 but could surge by as much as 57% from here

ADBE ALGN BLDR CARR CMG CPRT CRM

DEXCOM, INC. (NASDAQ: DXCM) INVESTOR ALERT Investors With Large Losses in DexCom, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Nov 14, 2025, 10:51 AM EST - 2 months ago

DEXCOM, INC. (NASDAQ: DXCM) INVESTOR ALERT Investors With Large Losses in DexCom, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Dexcom Reveals Global Diabetes Advocates: New Voices for Diabetes Awareness This World Diabetes Day

Nov 14, 2025, 8:00 AM EST - 2 months ago

Dexcom Reveals Global Diabetes Advocates: New Voices for Diabetes Awareness This World Diabetes Day

Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately

Nov 11, 2025, 9:18 AM EST - 2 months ago

Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately

DXCM STOCK NOTICE: DexCom, Inc. Investors with Losses may have been Misled by the Company and are Urged to Contact BFA Law by December 26 Deadline

Nov 10, 2025, 6:07 AM EST - 2 months ago

DXCM STOCK NOTICE: DexCom, Inc. Investors with Losses may have been Misled by the Company and are Urged to Contact BFA Law by December 26 Deadline

Québec Expands Access to Dexcom CGM under the Régie de l'assurance maladie du Québec (RAMQ)

Nov 6, 2025, 8:34 PM EST - 2 months ago

Québec Expands Access to Dexcom CGM under the Régie de l'assurance maladie du Québec (RAMQ)

Is Dexcom Stock A Buy Now?

Nov 3, 2025, 11:05 AM EST - 2 months ago

Is Dexcom Stock A Buy Now?

S&P 500 Gains and Losses Today: Amazon Stock Surges as Cloud Business Boosts Earnings; DexCom Drops

Oct 31, 2025, 4:55 PM EDT - 2 months ago

S&P 500 Gains and Losses Today: Amazon Stock Surges as Cloud Business Boosts Earnings; DexCom Drops

AMZN

DexCom Stock Is the Worst Performer in the S&P 500. Here's Why.

Oct 31, 2025, 10:17 AM EDT - 2 months ago

DexCom Stock Is the Worst Performer in the S&P 500. Here's Why.

20% Earnings Growth Potential For DexCom, Analyst Cites Buying Opportunity

Oct 31, 2025, 10:05 AM EDT - 2 months ago

20% Earnings Growth Potential For DexCom, Analyst Cites Buying Opportunity

Dexcom shares extend fall over 2026 growth concerns

Oct 31, 2025, 6:51 AM EDT - 2 months ago

Dexcom shares extend fall over 2026 growth concerns

DexCom, Inc. (DXCM) Q3 2025 Earnings Call Transcript

Oct 30, 2025, 8:26 PM EDT - 2 months ago

DexCom, Inc. (DXCM) Q3 2025 Earnings Call Transcript

Dexcom beats quarterly estimates on strong demand for glucose monitors

Oct 30, 2025, 4:03 PM EDT - 2 months ago

Dexcom beats quarterly estimates on strong demand for glucose monitors

Dexcom Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Guidance

Oct 30, 2025, 4:02 PM EDT - 2 months ago

Dexcom Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Guidance

DexCom Faces New Reports Of Deaths Linked To G7 Glucose Monitor

Oct 28, 2025, 2:04 PM EDT - 2 months ago

DexCom Faces New Reports Of Deaths Linked To G7 Glucose Monitor

Dexcom Appoints Euan Ashley to Board of Directors

Oct 27, 2025, 4:15 PM EDT - 2 months ago

Dexcom Appoints Euan Ashley to Board of Directors

10 stocks primed for growth in the S&P 500's cheapest sectors

Oct 23, 2025, 11:29 AM EDT - 2 months ago

10 stocks primed for growth in the S&P 500's cheapest sectors

BX AJG APO BRO FITB HOOD KKR

DexCom May Be The Most Underrated Growth Story In Healthcare

Oct 6, 2025, 6:39 AM EDT - 3 months ago

DexCom May Be The Most Underrated Growth Story In Healthcare

ckjamesst
ckjamesst Jan. 14 at 6:28 PM
$DXCM 67.62 is great close
0 · Reply
ckjamesst
ckjamesst Jan. 14 at 6:25 PM
$DXCM lets go to 66 boys
0 · Reply
ckjamesst
ckjamesst Jan. 14 at 3:38 PM
$DXCM don’t buy fk them bro. They want you to buy here so they can exit lol buy long puts :) gl
0 · Reply
ckjamesst
ckjamesst Jan. 14 at 3:28 PM
$DXCM 5k position entered
0 · Reply
DiamondCapital
DiamondCapital Jan. 14 at 2:27 PM
$ADHC Very attractive at 1M market cap Quick DD •GlucoGuard, diabetes medical device •FDA Breakthrough Device pending •Partnership with $DXCM a $27B co •Hedgefund backing •CFA Analyst coverage •Impressive team, including former FDA official Stephen Weber •University of California Irvine collab CFA Analyst report issued by Harbinger Research dated June 2, 2025 with a “Strong Speculative Buy” Rating with a price target of .012 or $43M valuation Link to the research report: https://d1io3yog0oux5.cloudfront.net/harbingerresearch/media/cf29499818e4263671232f93c2967e52.pdf By Brian R. Connell, CFA Senior Research Analyst | Harbinger Research
0 · Reply
ckjamesst
ckjamesst Jan. 14 at 12:37 PM
$DXCM please buy 2 weeks puts on this weak stock watch they are going to announce some bs soon either this week or next week I think spinning top is in play!
0 · Reply
ckjamesst
ckjamesst Jan. 14 at 12:25 PM
$DXCM to everyone who thinks this will go…. This is just for you all I am giving my buy zone area! I might be wrong but guess what I might be right as well. Next week is disaster.. trust the process. Can 58 or 59 is a buying zone ??
0 · Reply
ckjamesst
ckjamesst Jan. 14 at 12:09 AM
$DXCM this guy is a scammer
0 · Reply
ckjamesst
ckjamesst Jan. 13 at 11:45 PM
$DXCM tomorrow play is very simple: bull will try hard to push but they will fail. Huge rejection coming. If this moves slow expect it to drop till Monday next week. If it moves faster and drop then expect 62 or lower this week expecting 7-8% drop in few days
1 · Reply
Mobagri
Mobagri Jan. 13 at 11:03 PM
$DXCM https://stocks.apple.com/AK6kNTAPTRRSECTfBH86IXA
0 · Reply
BriOnH
BriOnH Jan. 13 at 10:30 PM
$DXCM https://www.youtube.com/watch?v=ntH7BciW8JE
0 · Reply
JInvestTrade
JInvestTrade Jan. 13 at 10:03 PM
$SENS , $DXCM , $TNDM , $PODD , $MDT https://www.linkedin.com/posts/senseonics-inc_senseonics-announces-first-commercial-patients-activity-7416833660223647744-CxCW?utm_medium=ios_app&rcm=ACoAACZifW0B2JqOqHkWvrhyPzzcI0ENdA47TYM&utm_source=social_share_send&utm_campaign=copy_link
0 · Reply
ckjamesst
ckjamesst Jan. 13 at 8:01 PM
$DXCM fsto going to kick in or momentum
0 · Reply
ckjamesst
ckjamesst Jan. 13 at 7:48 PM
$DXCM play puts everyone trust the process
0 · Reply
ckjamesst
ckjamesst Jan. 13 at 7:47 PM
$DXCM lets open at 66 tomorrow?
0 · Reply
ckjamesst
ckjamesst Jan. 13 at 6:16 PM
$DXCM best thing that Dxcm can do is just go to 55 level and let everyone buy one more time
1 · Reply
ckjamesst
ckjamesst Jan. 13 at 5:58 PM
$DXCM tomorrow is even blood bath
0 · Reply
ckjamesst
ckjamesst Jan. 13 at 5:46 PM
$DXCM one more thing:: fk their revenue when company is putting rebates 60% of revenue is vanished… I don’t care about their revenue anymore… they always beat guidance and company are doing terrible. They don’t even have a manufacturing company they lied to us
0 · Reply
ckjamesst
ckjamesst Jan. 13 at 4:31 PM
$DXCM they are mfking greedy hedge fund here becareful! They needed to be teach lesson. New CEO ain’t doing shit
0 · Reply
ckjamesst
ckjamesst Jan. 13 at 4:23 PM
$DXCM fraud n fda news incoming
0 · Reply
LQQKER_INSIDER
LQQKER_INSIDER Jan. 13 at 3:28 PM
$DXCM I guess it's safe to reveal these trades now too. 💋
0 · Reply
ckjamesst
ckjamesst Jan. 13 at 3:25 PM
$DXCM heavy selling hasn’t even begun. Dont buy at this level… wait for it to fall to liquid zone
0 · Reply